myeloMATCH Precision Medicine Clinical Trial Leverages Next-Day Genomic Testing to Quickly Match Patients with Appropriate Trials Across North America WALTHAM, Mass. — To help accelerate research into new treatments for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS), Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, is partnering with the National […]
Predictive tools will seek to reduce leading cause of failure rates in clinical trials of oncology drugs. Integrated AI and microscopy expected to lead to better understanding of tumor structures and treatment strategies. New technology will work to capture and analyze the highly heterogeneous tumor microenvironment. WASHINGTON — Danaher Corporation (NYSE: DHR), a global science and […]
Eurofins Clinical Enterprise, LLC and SeqMatic first providers to join program, expanding access to Parse’s growing single cell portfolio SEATTLE — Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced the launch of its Certified Service Provider (CSP) Program. For researchers who are seeking paths to outsource their single […]
Former Agena Bioscience EVP and GM to lead Mission Bio’s marketing, sales, and customer support efforts SOUTH SAN FRANCISCO, Calif. – Mission Bio, a leader in single-cell multiomics solutions for precision medicine, today announced the appointment of Roman Haehn as Chief Commercial Officer. Drawing on more than 25 years of experience in diagnostics and life sciences […]
Nijmegen, Netherlands – MGI (MGI Tech Co., Ltd. or its subsidiaries, together referred to MGI), a company committed to building core tools and technologies that drive innovation in life science, today announced the collaboration with Predica Diagnostics, a leading innovator in oncology diagnostics, to develop Predica’s targeted RNA sequencing tests on the cost-effective MGI Next-generation […]
BugSeq, an innovative biotech company that provides a user-friendly and rapid bioinformatics platform for clinical and public health laboratories, announces it has entered a public-private partnership with the Biomedical Advanced Research and Development Authority‘s (BARDA) Division of Research, Innovation, and Ventures (DRIVe) to develop an artificial intelligence (AI)-powered reporting tool for clinical metagenomics data. BARDA is […]
Express Genes enable faster turnaround times Twist Express Antibodies, CHO starting at 13 business days Twist Express Antibodies, HEK293 starting at 10 business days SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the expansion of […]
Illumina has signed a research collaboration agreement with the National Cancer Centre Singapore to better diagnose and treat adolescent and young adult (AYA) lymphoma in Asian cohorts, potentially benefiting more than 1000 patients in Singapore per year. As part of the agreement, Illumina will support with its industry-leading genome sequencing platforms, including the NovaSeq™ 6000. […]
SAN DIEGO, CA – Element Biosciences, Inc., developer of pioneering technologies to empower science, today announced over $277 million in Series D investment to support its growing global customer base with disruptive DNA sequencing and multi-omics technologies for years to come. The oversubscribed round was led by Wellington Management with participation from new and existing […]
BOSTON — CytoTronics, Inc., a pioneer of semiconductor-based platforms for discovery in cell biology, introduced its high-throughput Pixel™ Octo system at the International Society for Stem Cell Research (ISSCR 2024) in Hamburg, Germany. This new addition to the Pixel lineup integrates the company’s semiconductor-to-live-cell interface in an environmental controlled benchtop system to deliver live cell measurements […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
